C

Celllular Biomedicine Group

6 employees

CBMG is a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancers and stem cell therapies.

Basic info

Industry

biotechnology research

Sectors

Medical Device
Biotechnology
Dendritic Cells
Biomedicine
Therapeutics
Embryonic Stem Cells
Progenitor Cells

Date founded

2009

Funding rounds raised

Total raised

$120M

from 5 investors over 5 rounds

C

Celllular Biomedicine Group raised $120M on September 28, 2021

Investors: 泰福资本 TF Capital, GIC and Sequoia Capital China

C

Celllular Biomedicine Group raised $31M on February 7, 2018

Investors: Sailing Capital

C

Celllular Biomedicine Group raised $43M on February 5, 2016

Investors: Dangdai International Group Co., Limited

FAQ